Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, $0.00001 par value
-
Shares outstanding
-
19.1M
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
3.64M
-
Shares change
-
-642K
-
Total reported value, excl. options
-
$19.8M
-
Value change
-
-$3.15M
-
Put/Call ratio
-
0.06
-
Number of buys
-
20
-
Number of sells
-
-14
-
Price
-
$5.44
Significant Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) as of Q1 2024
42 filings reported holding NVNO - enVVeno Medical Corp - Common Stock, $0.00001 par value as of Q1 2024.
enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.64M shares
of 19.1M outstanding shares and own 19.03% of the company stock.
Largest 10 shareholders include KINGDON CAPITAL MANAGEMENT, L.L.C. (654K shares), PERCEPTIVE ADVISORS LLC (623K shares), VANGUARD GROUP INC (574K shares), Nantahala Capital Management, LLC (496K shares), OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) (226K shares), ADAR1 Capital Management, LLC (202K shares), Velan Capital Investment Management LP (172K shares), GEODE CAPITAL MANAGEMENT, LLC (137K shares), MORGAN STANLEY (97.6K shares), and CITADEL ADVISORS LLC (45.6K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.